Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

734.26 +1.68 (+0.23%)
Streaming Delayed Price Updated: 3:12 PM EDT, Sep 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,231,077
Open 727.99
Bid (Size) 733.80 (1)
Ask (Size) 734.60 (1)
Prev. Close 732.58
Today's Range 723.64 - 737.14
52wk Range 623.78 - 969.65
Shares Outstanding 956,580,893
Dividend Yield 0.82%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Inflation's Stubborn Grip: PCE Index and Fed's Dilemma
The specter of persistent inflation continues to loom large over the U.S. economy, keeping both consumers and policymakers on edge. Despite the Federal Reserve's aggressive campaign of interest rate... 
Via MarketMinute
Topics Bonds Economy Supply Chain
EXCLUSIVE: August's 20 Most-Searched Tickers On Benzinga Pro – Where Do Opendoor, Palantir, BitMine Immersion, Apple Stock Rank?
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers. 
Via Benzinga

Performance

YTD
-5.6%
-5.6%
1 Month
-4.5%
-4.5%
3 Month
-1.7%
-1.7%
6 Month
-21.0%
-21.0%
1 Year
-23.2%
-23.2%

More News

Read More
Eli Lilly’s Weight-Loss Star Mounjaro Paused In UK Until September Ahead Of Massive Price Jump
Via Stocktwits
Novo Nordisk's Wegovy Outshines Eli Lilly's Tirzepatide In Reducing Risk Of Heart Attack, Stroke And Death
Via Benzinga
Unpacking Q2 Earnings: Elanco (NYSE:ELAN) In The Context Of Other Pharmaceuticals Stocks
Via StockStory
Topics Artificial Intelligence Intellectual Property
Benzinga Bulls And Bears: Eli Lilly, Firefly, Marvell — And Trump Investment Hints Boost Defense Stocks
Via Benzinga
Topics Government
FDA Approves Biogen, Eisai's Highly Anticipated Alzheimer's Treatment
Via Investor's Business Daily
The Great Rebalancing: Equity Markets Pivot from Tech Giants to Value and Cyclical Stocks
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
Eli Lilly Is Proof That Wall Street Stars Don't Have To Be Tech Titans
Via Benzinga
Novo Nordisk Slowdown Weighs On Denmark's Economic Outlook
Via Benzinga
FDA Tightens Safety Guidelines For Biogen Leqembi Alzheimer's Therapy
Via Benzinga
Nvidia's $46.7 Billion Quarter Shows the AI Trade Is Alive and Well -- With Caveats
Via The Motley Fool
Topics Artificial Intelligence
2 Beaten-Down Stocks That Could Rocket 142% to 222% Higher, According to Wall Street Analysts
Via The Motley Fool
The Unsettling Dance: Robust Growth and Stubborn Inflation Challenge the Fed's Resolve
Via MarketMinute
Topics Bonds Economy Energy
Stock Of The Day: Another Breakout For Eli Lilly?
Via Benzinga
Prothena Reports Non-Competitive Brain Swelling Rates In Early Alzheimer's Study
Via Benzinga
Global Trade Braces for Impact: US-China Tariff Tensions Persist Amidst Fleeting Truces and Escalating Duties
Via MarketMinute
Topics Artificial Intelligence Economy Government
This Pharma Major’s Stock Has Lost 59% Of Its Value In A Year – Why Is It Drawing Investor Interest Today?
Via Stocktwits
2 Growth Stocks That Could Be Worth $1 Trillion in 5 Years
Via The Motley Fool
Novo Nordisk Eyes New Arena Amid Weight-Loss Market Pressure
Via Investor's Business Daily
The Invesco QQQ Trust Has a Glaring Flaw by Excluding This "Ten Titans" Stock and 3 Other Megacap Growth Stocks. Here's an ETF That Corrects the Error.
Via The Motley Fool
Topics Artificial Intelligence ETFs
UK Patients Scramble For Mounjaro As Eli Lilly's 170% Price Hike Plan Sparks Shortages, Health Fears
Via Benzinga
Stevens Capital Closes Out Position in Eli Lilly
Via The Motley Fool
2 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade
Via The Motley Fool
Market Movers: Unpacking the Forces Behind Recent Stock Swings
Via MarketMinute
Topics Artificial Intelligence Earnings Economy

Frequently Asked Questions

Is Eli Lilly publicly traded?
Yes, Eli Lilly is publicly traded.
What exchange does Eli Lilly trade on?
Eli Lilly trades on the New York Stock Exchange
What is the ticker symbol for Eli Lilly?
The ticker symbol for Eli Lilly is LLY on the New York Stock Exchange
What is the current price of Eli Lilly?
The current price of Eli Lilly is 734.26
When was Eli Lilly last traded?
The last trade of Eli Lilly was at 09/02/25 03:12 PM ET
What is the market capitalization of Eli Lilly?
The market capitalization of Eli Lilly is 702.38B
How many shares of Eli Lilly are outstanding?
Eli Lilly has 702B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.